is_manufactured_by has function has role has component immunizes against disease immunizes recipient immunizes against pathogen has drug brand name haemophilus meningitis Homo sapiens PedvaxHIB vaccine Liquid PedvaxHIB VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=161 PMID:2791073 Kallan Roan https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM253652.pdf Oliver He BL 103237/5285 vaccine https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm253644.htm Liquid PedvaxHIB is indicated for routine vaccination against invasive disease caused by Haemophilus influenzae type b in infants and children 2 to 71 months of age. PedvaxHIB is a highly purified capsular polysaccharide (polyribosylribitol phosphate or PRP) of Haemophilus influenzae type b (Haemophilus b, Ross strain) that is covalently bound to an outer membrane protein complex (OMPC) of the B11 strain of Neisseria meningitidis serogroup B. 161 FDA licensed vaccine role conjugate vaccine USA licensed human vaccine preventive vaccine function prophylactic vaccine conjugate vaccine role Haemophilus influenzae serotype b vaccine Haemophilus influenzae serotype b vaccine conjugate protein Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine vaccine monovalent role licensed human haemophilus influenzae serotype b vaccine Merck & Co., Inc. PedvaxHIB